Yahoo Web Search

Search results

1. Explore more companies

   • 

     Abbott Laboratories

   • 

     Amgen

   • 

     Allergan

   • 

     Merck & Co.

   • 

     Pfizer

   • 

     Johnson & Johnson

   • Biogen

   • Vertex Pharmaceuticals

   • AstraZeneca

   • Gilead Sciences

   • Allergan, Inc.

   • UnitedHealth Group

   • Eli Lilly and Company

   • Bristol Myers Squibb

   • Regeneron Pharmaceuticals

2. Abbvie - Local Result

   • 

   • A
     AbbVie

     Pharmaceutical Manufacturer

     24025 Park Sorrento, Calabasas, CA · (818) 876-7770
     
     Website
   Add or update your business

3. www.abbvie.comPharmaceutical Research & Development | AbbVie

   www.abbvie.com

   • Cached

   May 7, 2024 · AbbVie is a global biopharmaceutical company that invests in science and innovation to treat 75+ conditions and improve lives. Learn about its R&D, partnerships, sustainability, careers and investor resources.

   • Join Us

     AbbVie Foundation Partners Scale Efforts to Advance Racial...

   • Products

     employees turning possibilities into reality for people and...

     Patients

     · Pipeline

     · Why AbbVie

     · Opportunities

     · Therapeutic Focus Areas

     · Technologies & Platforms

   • Investor Overview

     AbbVie discovers, develops, and commercializes advanced...

     Shareholder Contacts

     · Financial Releases

     · Presentations

     · SEC Filings

     · Financials

     · Resources

   • Who We Are

     AbbVie was founded in 2013 when we became a separate company...

   • Partner with Us

     AbbVie Neuroscience portfolio consists of approved therapies...

   • Patient Support

     AbbVie help patients get the medicines and solutions they...

   • Latest News

     - AbbVie will present 15 abstracts, including three oral...

     Media Resources

     · Images

     · Video

   • Fact Sheets

     News Center | AbbVie News Center

     Corporate Fact Sheet

     · Our Impact

   • Media Contacts

     gabrielle.tarbert@abbvie.com or...

   • Events and Presentations

     AbbVie cautions that these forward-looking statements are...

4. finance.yahoo.com › quote › ABBVAbbVie Inc. (ABBV) Stock Price, News, Quote & History - Yahoo ...

   finance.yahoo.com › quote › ABBV

   • Cached

   Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing.

5. Videos

   • 

     0:19

     instagram.com

     A culture of curiosity drives our #scientists' pursuit of new approaches to tackle #BloodCancer. Click the link 🔗 in today’s story to see what they’re working on next. #WorldBloodCancerDay[Video description: Animation depicting cells and a scientist. On-screen text reads, "Oncology research is in a renaissance. In less than 30 years, survival rates have nearly doubled for some blood cancers. And tomorrow’s treatments can help take us even further. See what scientists are working on next."]

     May 28, 2024

     256 Views

   • 

     12:16

     youtube.com

     Abbvie Stock Analysis - ABBV stock | 4% Dividend Yield

     May 28, 2024

     2 Views

   • 

     2:53

     youtube.com

     Opening up about complex Parkinson’s: Laurel's Story

     May 27, 2024

     130 Views

   View all

6. en.wikipedia.org › wiki › AbbVieAbbVie - Wikipedia

   en.wikipedia.org › wiki › AbbVie

   • Cached

   AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.

7. www.abbvie.com › patientsPatients | AbbVie - Pharmaceutical Research & Development

   www.abbvie.com › patients

   • Cached

   AbbVie is a global biopharmaceutical company that puts patients first in its research, development and access programs. Learn how AbbVie creates medicines and solutions that make a difference in people's lives, and explore its partnerships, sustainability and patient support initiatives.

8. Top Stories

   • 
     Seeking Alpha on MSN.com

     AbbVie shares fell for seven straight days

     AbbVie (NYSE:ABBV) shares traded in the red on Wednesday, making it the seventh straight days of losses. Stock closed down 0.32% at $154.85. ABBV has risen 13.2% in the last 12 months and fallen 3.8% in the last one month.

     4 hours ago

   • 

     Seeking Alpha

     Looking For Both Income And Growth? 4%-Yielding AbbVie Has You Covered

     3 hours ago

   • 

     Zacks.com on MSN.com

     AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It

     11 hours ago

   • 

     Zacks.com on MSN.com

     Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?

     3 hours ago

   • Business Insider

     The Analyst Verdict: AbbVie In The Eyes Of 5 Experts

     2 weeks ago

   View all

9. news.abbvie.com › 2023/11/30-AbbVie-to-AcquireAbbVie to Acquire ImmunoGen, including its Flagship Cancer ...

   news.abbvie.com › 2023/11/30-AbbVie-to-Acquire

   • Cached

   Nov 30, 2023 · NORTH CHICAGO, Ill., and WALTHAM, Mass., Nov. 30, 2023 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) and ImmunoGen, Inc. (NASDAQ: IMGN) today announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship cancer therapy ELAHERE ® (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC ...

10. news.abbvie.com › 2024/03/25-AbbVie-to-AcquireAbbVie to Acquire Landos Biopharma, Further Strengthening its ...

    news.abbvie.com › 2024/03/25-AbbVie-to-Acquire

    • Cached

    Mar 25, 2024 · NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ: LABP) ("Landos") today announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for patients ...

11. People also ask

    How much does AbbVie cost?

    • First released in 2003, AbbVie has since raised the price of Humira by more than 470%, culminating in an annual supply costing about $77,000. It has increased the price of Imbruvica, a drug used to treat mantle cell lymphoma and other cancers, by 82% since it launched in 2013. In 2022, it was priced at $181,529.

    AbbVie - Wikipedia

    en.wikipedia.org/wiki/AbbVie

    See all results for this question

    Is AbbVie a tax inversion?

    • On 25 June 2019, AbbVie announced it would acquire Irish-based Allergan plc for about $63 billion; however the transaction would not be structured as a tax inversion, and that post the transaction, AbbVie would remain legally domiciled in the U.S. for tax purposes. The company divested certain assets to gain FTC approval.

    AbbVie - Wikipedia

    en.wikipedia.org/wiki/AbbVie

    See all results for this question

    What does AbbVie do?

    • AbbVie strives to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in AbbVie's Allergan Aesthetics portfolio.

    AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio

    news.abbvie.com/2024-03-25-AbbVie-to-Acquire-Landos-Biopharma,-Further-Strengthening-its-Portfolio-in-Inflammatory-and-Autoimmune-Diseases

    See all results for this question

    Where can I find more information about AbbVie?

    • For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. About Landos Biopharma Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases.

    AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio

    news.abbvie.com/2024-03-25-AbbVie-to-Acquire-Landos-Biopharma,-Further-Strengthening-its-Portfolio-in-Inflammatory-and-Autoimmune-Diseases

    See all results for this question